Five-year outcomes of the early-generation Intrepid transapical transcatheter mitral valve replacement system
Gilbert H.L. Tang(Mount Sinai Health System), Michael J. Reardon(Houston Methodist), Renuka Jain(Aurora St. Luke's Medical Center), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Jeremy J. Thaden(Mayo Clinic in Arizona), Vinayak Bapat(Abbott Northwestern Hospital), Antony Walton, Konstantinos Spargias(Hygeia Hospital), Mika Laine(Helsinki University Hospital), Patrick M. McCarthy(Northwestern Medicine), Alan Zajarías(Washington University in St. Louis), Tanvir Bajwa(Aurora Health Care), Mathew Williams(Mount Sinai Health System), Paul Sorajja(Abbott Northwestern Hospital), Ronak Rajani(Guy's and St Thomas' NHS Foundation Trust), David Adams(Mount Sinai Health System), Didier Tchétché(Clinique Pasteur), Vivek Rajagopal(Piedmont Atlanta Hospital), Thomas Modine(Hôpitaux Universitaires Henri-Mondor), Martin B. Leon(Columbia University Irving Medical Center), Randolph P. Martin(Emory University), Ole De Backer(Rigshospitalet), Martin K.C. Ng(Royal Prince Alfred Hospital), Daniel Blackman, Robert Gooley(Australian Centre for Heart Health), David Hildick‐Smith(Royal Sussex County Hospital), Nicholas Marka(University of Minnesota)
Cited by 3
Related Papers
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.7k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k